CocoaNol®
1,000 mg of high-flavanol cocoa extract — the eNOS activator associated with improved neurovascular coupling, increased cerebral blood flow by 8% in healthy elderly adults (n=34), and improves cognitive processing speed by up to 29% in subjects with impaired neurovascular coupling at baseline.
Primacy Research
What CocoaNol® Does For You
+8% Cerebral Blood Flow in 2 Weeks
Sorond et al. (2008) demonstrated an 8% increase in middle cerebral artery blood flow velocity within just 2 weeks of high-flavanol cocoa supplementation in healthy elderly adults.
Neurovascular Coupling Restoration
Sorond et al. (2013) showed restoration of impaired neurovascular coupling after 30 days, correlated with faster cognitive processing on Trail Making Test-B in subjects with baseline impairments.
eNOS Activation via PI3K/Akt
(-)-Epicatechin activates the PI3K/Akt signaling pathway, phosphorylating eNOS at Ser1177 to increase nitric oxide production — an enzyme activation mechanism independent of arginine substrate supply.
Insulin Resistance Reduction Mediates Cognition
In older adults with cognitive concerns, Desideri et al. (2012) demonstrated that cocoa flavanols reduced insulin resistance (HOMA-IR), and this metabolic improvement statistically mediated ~40% of the cognitive benefit.
Dual NO Pathway with NooLVL®
CocoaNol® activates the enzyme (eNOS) while NooLVL® provides the substrate (arginine). Two independent rate-limiting factors addressed simultaneously for maximum nitric oxide output.
Your Brain’s Blood Flow Can’t Keep Up
Neurovascular coupling — the brain’s ability to dynamically route blood flow to active neural regions — is the hemodynamic foundation of sustained cognitive performance. It declines measurably from the 40s onward as endothelial function degrades, eNOS activity drops, and nitric oxide bioavailability falls. The result: your brain’s processing capacity is bottlenecked not by neurons, but by the blood vessels that feed them.
Neurovascular Coupling Decline
NVC declines with age, metabolic syndrome, and sedentary behavior. When active brain regions can’t recruit additional blood flow fast enough, cognitive processing slows — particularly on tasks requiring sustained attention, executive function, and rapid switching.
Endothelial Dysfunction
eNOS expression decreases with age. Superoxide radicals scavenge available NO, converting it to toxic peroxynitrite. The vascular endothelium — the single-cell layer controlling vasodilation — becomes progressively dysfunctional, reducing NO-mediated blood flow regulation.
Insulin Resistance and Cognition
Brain insulin resistance impairs glucose uptake in hippocampal neurons, degrading memory consolidation. Endothelial dysfunction and insulin resistance are mechanistically linked — both trace back to impaired PI3K/Akt signaling that cocoa flavanols directly target.
How CocoaNol® Works
CocoaNol® delivers concentrated cocoa flavanols — primarily (-)-epicatechin — that activate eNOS through a mechanism independent of arginine substrate. While NooLVL® provides the raw material for NO production, CocoaNol® is designed to support the enzyme machinery that drives NO synthesis.
eNOS Activation via PI3K/Akt
(-)-Epicatechin activates the PI3K/Akt signaling pathway in endothelial cells, leading to phosphorylation of eNOS at Ser1177. This increases eNOS catalytic activity — producing more NO per unit of arginine substrate. Fisher et al. confirmed this mechanism is abolished by the eNOS inhibitor L-NAME.
NO Protection from Oxidative Degradation
Cocoa flavanols inhibit NADPH oxidase, reducing superoxide production that scavenges NO. They also activate Nrf2, upregulating endogenous antioxidant enzymes (HO-1, NQO1). This means more of the NO produced by eNOS reaches vascular smooth muscle intact — extending its vasodilatory effect.
Cerebral Blood Flow + Neurovascular Coupling
Sorond et al. (2008) showed an 8% increase in cerebral blood flow velocity within 2 weeks. Sorond et al. (2013) showed restoration of impaired neurovascular coupling — the brain’s ability to dynamically fuel active regions. Cognitive improvement (29% faster TMT-B) correlated with NVC restoration.
Epicatechin Crosses the BBB
(-)-Epicatechin crosses the blood-brain barrier and acts directly in neural tissue. Preclinical work suggests it promotes angiogenesis (new capillary formation), increases dendritic spine density, and upregulates BDNF. These are neuronal effects independent of the vascular pathway — positioning epicatechin as both a vascular and a potential direct neurotrophic agent.
Insulin Sensitization → Cognitive Benefit
Desideri et al. (2012) showed that cocoa flavanols significantly reduced insulin resistance (HOMA-IR) in older adults with cognitive concerns, and that this metabolic improvement statistically mediated the cognitive benefits. Better insulin signaling → better hippocampal glucose uptake → better memory consolidation.
What the Research Shows
CocoaNol® is supported by multiple randomized, controlled trials demonstrating cerebrovascular, cognitive, and metabolic benefits across elderly and older adult populations with cognitive concerns.
Sorond et al. (2013). Neurology, 81(10):904-909. ~900 mg cocoa flavanols/day for 30 days. NVC restoration correlated with cognitive improvement.
Desideri et al. (2012). Hypertension, 60(3):794-801. CoCoA Study. ~990 mg flavanols/day for 8 weeks in MCI. Cognitive improvement mediated by insulin resistance reduction.
Sorond et al. (2008). Neuropsychiatric Disease and Treatment, 4(2):433-440. ~900 mg cocoa flavanols/day for 2 weeks. +8% CBFV.
Your Daily Dose in APEX
Why this dose works: 1,000 mg of high-flavanol cocoa extract (standardized for flavanol content) delivers a concentrated dose of epicatechin and procyanidins. The flavanol content depends on the extract’s standardization percentage — 1,000 mg of extract does not equal 1,000 mg of flavanols. Clinical benefits are demonstrated at both ~500 mg and ~1,000 mg flavanol doses, with dose-response evidence favoring higher intakes. APEX maximizes the perfusion benefit alongside NooLVL® for dual-pathway NO architecture.
How CocoaNol® Connects Across the System
CocoaNol® is the enzymatic half of APEX’s dual NO architecture. Inside the Primacy protocol, it connects vascular, metabolic, and neurotrophic pathways across both products.
Dual NO Architecture — Enzyme + Substrate
NooLVL® provides arginine (the substrate). CocoaNol® activates eNOS (the enzyme) and protects NO from superoxide scavenging. Two independent rate-limiting factors addressed simultaneously. More raw material + upgraded machinery + less waste.
Vascular-Metabolic Convergence
CocoaNol® improves endothelial function (NO pathway) AND insulin sensitivity (PI3K/Akt). Ceylon Cinnamon provides parallel insulin sensitization via AMPK. Desideri et al. reported that insulin resistance mediated cocoa’s cognitive benefits in older adults with cognitive concerns — supporting this metabolic synergy rationale.
AM/PM Endothelial Support
CocoaNol® is designed to drive eNOS activation and NO-mediated perfusion during the day. Pycnogenol® in RESET is intended to continue endothelial support overnight — positioned to protect blood vessel integrity and maintain NO bioavailability across the circadian cycle.
Key Takeaways
+8% Cerebral Blood Flow in 2 Weeks
Sorond et al. (2008) demonstrated an 8% increase in middle cerebral artery blood flow velocity within just 2 weeks of high-flavanol cocoa supplementation — a rapid, measurable improvement in brain perfusion.
Neurovascular Coupling Restored
Sorond et al. (2013) showed NVC restoration in impaired subjects correlated with 29% faster cognitive processing on Trail Making Test-B — demonstrating the direct link between blood flow regulation and cognitive speed.
Insulin Resistance Mediates Cognitive Benefit
Desideri et al. (2012) demonstrated a mediation pathway: flavanols were associated with reduced insulin resistance and improved cognition. This is one of the few supplement studies to show a statistically mediated mechanism for cognitive improvement.
Dual NO Pathway with NooLVL®
CocoaNol® activates the enzyme (eNOS); NooLVL® provides the substrate (arginine). Two independent mechanisms maximizing NO output — a dual-pathway architecture that neither ingredient can achieve alone.
Frequently Asked Questions
What is CocoaNol®?
CocoaNol® is a high-flavanol cocoa extract delivering concentrated cocoa flavanols, primarily (-)-epicatechin. It activates eNOS (the enzyme that produces nitric oxide) through the PI3K/Akt pathway, supporting cerebral blood flow and neurovascular coupling independently of arginine substrate.
How does cocoa improve brain blood flow?
Cocoa flavanols activate eNOS via PI3K/Akt signaling, increasing nitric oxide production. NO relaxes cerebral vascular smooth muscle, increasing blood flow. Sorond et al. (2008) measured an 8% increase in cerebral blood flow velocity within 2 weeks, and Sorond et al. (2013) showed restoration of impaired neurovascular coupling after 30 days.
How does CocoaNol® work with NooLVL®?
NooLVL® provides arginine (the raw material for NO). CocoaNol® activates eNOS (the enzyme) and protects NO from superoxide scavenging. Two independent rate-limiting factors addressed simultaneously — more substrate + more active machinery + less waste = maximized NO output.
Does cocoa help with insulin resistance?
Yes. Desideri et al. (2012) showed that high-flavanol cocoa significantly reduced insulin resistance (HOMA-IR) in older adults with cognitive concerns over 8 weeks, and that this metabolic improvement statistically mediated approximately 40% of the observed cognitive benefit. The PI3K/Akt pathway targeted by epicatechin is shared between eNOS activation and insulin signaling.
Does epicatechin cross the blood-brain barrier?
Yes. (-)-Epicatechin crosses the BBB and acts directly in neural tissue. Preclinical evidence suggests it promotes angiogenesis (new capillary formation), increases dendritic spine density, and upregulates BDNF — positioning it as both a vascular and a direct neurotrophic agent.
How much CocoaNol® is in APEX?
APEX delivers 1,000 mg of CocoaNol® (high-flavanol cocoa extract standardized for flavanol content) per serving. Note that 1,000 mg refers to the total extract weight — the flavanol content depends on the standardization percentage. Clinical benefits are demonstrated at both ~500 mg and ~1,000 mg flavanol doses, with dose-response evidence favoring higher intakes for cerebrovascular and cognitive outcomes.
References
- [1]Sorond, F. A., Hurwitz, S., Salat, D. H., Greve, D. N., & Fisher, N. D. L. (2013). Neurovascular coupling, cerebral white matter integrity, and response to cocoa in older people. Neurology, 81(10), 904–909.View
- [2]Desideri, G., et al. (2012). Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: The Cocoa, Cognition, and Aging (CoCoA) study. Hypertension, 60(3), 794–801.View
- [3]Sorond, F. A., Lipsitz, L. A., Hollenberg, N. K., & Fisher, N. D. L. (2008). Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans. Neuropsychiatric Disease and Treatment, 4(2), 433–440.View
Upgrade Your Cerebrovascular Performance
CocoaNol® is one of 28 active ingredients in APEX, engineered to work as a system — not a stack of standalone compounds.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.